The average one-year price target for TrueBlue (NYSE:TBI) has been revised to $8.67 / share. This is an increase of 10.87% from the prior estimate of $7.82 dated November 14, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $7.07 to a high of $10.50 / share. The average price target represents an increase of 76.94% from the latest reported closing price of $4.90 / share.
What is the Fund Sentiment?
There are 282 funds or institutions reporting positions in TrueBlue. This is an decrease of 8 owner(s) or 2.76% in the last quarter. Average portfolio weight of all funds dedicated to TBI is 0.05%, an increase of 2.52%. Total shares owned by institutions increased in the last three months by 1.99% to 36,311K shares. 
The put/call ratio of TBI is 0.03, indicating a bullish outlook.
What are Other Shareholders Doing?
Pzena Investment Management holds 2,892K shares representing 9.66% ownership of the company. In its prior filing, the firm reported owning 2,919K shares , representing a decrease of 0.95%. The firm decreased its portfolio allocation in TBI by 8.07% over the last quarter.
Royce & Associates holds 2,315K shares representing 7.73% ownership of the company. In its prior filing, the firm reported owning 2,360K shares , representing a decrease of 1.94%. The firm decreased its portfolio allocation in TBI by 9.84% over the last quarter.
Invesco holds 1,858K shares representing 6.20% ownership of the company. In its prior filing, the firm reported owning 1,907K shares , representing a decrease of 2.65%. The firm decreased its portfolio allocation in TBI by 90.04% over the last quarter.
VSCAX - Invesco Small Cap Value Fund holds 1,779K shares representing 5.94% ownership of the company. In its prior filing, the firm reported owning 1,721K shares , representing an increase of 3.31%. The firm increased its portfolio allocation in TBI by 47.17% over the last quarter.
Boston Partners holds 1,614K shares representing 5.39% ownership of the company. In its prior filing, the firm reported owning 777K shares , representing an increase of 51.85%. The firm decreased its portfolio allocation in TBI by 25.58% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
